PLD3 and early-onset autosomal dominant Alzheimer disease: Recent studies suggest that Alzheimer’s disease-associated mutations in PLD3 abrogate its putative phospholipase activity7,11 and modulating PLD3 levels has been shown to cause an enlargement of endolysosomal vesicles12,13.